Niki BiosolutionsNIKI
13F holders, Q2 2025 (June 30)4holders −4
0new positions
4sold out
$0.91avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings, down 4 from Q1 2025. 0 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($34K), Osaic Holdings, Inc. ($5K) and Citigroup Inc. ($907).
- Company
- Niki Biosolutions Inc.
- Filed as
- APTORUM GROUP LIMITED (Q2 2025)
- CUSIP
- G6096M122
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $43K |
All 13F filers, Q1 2025 → Q2 2025: 1,478 shares bought and 51,814 shares sold, net −50,336 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Geode Capital Management, LLC | 0.00% | Add +1.4% | 37,449 | $34K |
| Osaic Holdings, Inc. | 0.00% | No change | 5,500 | $5K |
| Citigroup Inc. | 0.00% | Add +5136.8% | 995 | $907 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -89.5% | 7 | $6 |
"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.